No Data
Hong Kong stock Concept tracking | Promoting the value assessment and allocation of Traditional Chinese Medicine Pharmaceuticals, Institutions are Bullish on the recovery of Traditional Chinese Medicine revenue (with attached Concept stocks)
The General Office of the State Council issued the "Opinions on Improving the Quality of Traditional Chinese Medicine and Promoting the High-Quality Development of the Traditional Chinese Medicine Industry."
TONG REN TANG (01666.HK): Permitted to sell "Jin Chai Shi Hu San [TONG REN TANG]" in Hong Kong.
On March 20, Gelonghui reported that TONG REN TANG (01666.HK) announced that its subsidiary TONGRENTANGCM recently received the "Chinese Patent Medicine Registration Certificate" issued by the Hong Kong Chinese Medicine Council, which allows the sale of "Jinchai Shihudsan [TONG REN TANG]" in Hong Kong. Pharmaceutical name: Jinchai Shihudsan [TONG REN TANG]. Registered holder and address: Peking TONGRENTANGCM Ltd., 3 Da Jing Street, Tai Po Industrial Estate, New Territories, Hong Kong. Registration number: HKC-18754. Certificate validity period: until January 23, 2030. It is reported that the main function of "Jinchai Shihudsan [TONG REN TANG]" is for use in treating febrile diseases with injury to fluids, with a pleasant taste.
Express News | Tong Ren Tang Technologies - Certificate of Registration of Proprietary Chinese Medicine Issued by Chinese Medicine Council of Hong Kong
TONG REN TANG: NOTICE OF BOARD MEETING
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
China Securities Co.,Ltd.: Policy encouragement + new technology promotion + overseas opportunities create new chances, maintaining a bullish outlook on the Innovative Drugs industry.
National policies encourage the development of Innovative Drugs, new technologies promote the rapid growth of the Industry, new opportunities arise for going overseas, and there is a continuous Bullish outlook for the Innovative Drugs Industry.
The Five-year Shareholder Returns and Company Earnings Persist Lower as Tong Ren Tang Technologies (HKG:1666) Stock Falls a Further 6.9% in Past Week
